BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 2018
View Archived Issues
Acrizanib shows efficacy as topical ocular therapy in models of choroidal neovascularization
Read More
Patient enrollment ongoing in phase I trial of HA-1 T TCR T-cell Immunotherapy
Read More
Samsung Bioepis initiates phase III trial of proposed ranibizumab biosimilar, SB-11
Read More
ST-002 is granted FDA orphan drug designation
Read More
Terns Pharmaceuticals acquires three therapeutic candidates for the treatment of NASH from Lilly
Read More
AmnioStem cells show superior immune modulatory ability compared to other stem cell types
Read More
MCM7 found as a useful marker for intestinal NET grading
Read More
Tie1 is a biomarker of survival in patients with metastatic breast cancer
Read More
Karo Pharma resolves rights issue regarding acquisition of product portfolio from LEO Pharma
Read More
Ubiquigent, FORMA Therapeutics enter DUB enzyme inhibitor collaboration
Read More
Biogen and Samsung Bioepis cleared to commercialize Imraldi following AbbVie settlement
Read More
Sorrento Therapeutics and Celularity start screening for CD38 CAR-T therapy phase I trial
Read More
Ferring Pharmaceuticals to acquire Rebiotix
Read More
Strategic collaboration agreement between Nektar and Bristol-Myers Squibb becomes effective
Read More
Takeda and DNDi collaborate to develop potential novel drug for visceral leishmaniasis
Read More
Injectable hydrogel releases corticosteroid in response to arthritis flares
Read More
First cohort dosed in phase I clinical study of PB-2452
Read More
Vaccibody initiates first-in-human trial of neoantigen cancer vaccine
Read More
SOX-9 successfully distinguishes hepatocellular carcinoma from cholangiocarcinoma
Read More
Biopharma Works patents novel serine racemase inhibitors
Read More
Menin/MLL interaction inhibitors disclosed by Vitae Pharmaceuticals
Read More
Arbutus Biopharma identifies new HBV capsid inhibitors
Read More
Aurigene Discovery Technologies divulges new PD-1 inhibitors
Read More
Genoscience Pharma initiates first-in-human study of GNS-561 in advanced hepatocellular carcinoma
Read More
Decreased OXTR gene methylation tied to schizophrenia
Read More
European Commission grants marketing authorization to Lamzede
Read More
New phase IIb study explores use of sepranolone for premenstrual dysphoric disorder
Read More